Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer [Phase 1]
This Phase 1 trial evaluated interleukin-12 in patients with refractory advanced-stage ovarian cancer or abdominal cancer and the study stat…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors
This clinical trial update reports an ex vivo study evaluating the combination of platinum chemotherapy with the BH3-mimetic ABT-737 in ovar…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer [Phase 1]
Phase 1 trial evaluating a radiolabeled monoclonal antibody with paclitaxel and interferon alfa in patients with recurrent ovarian cancer ha…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer [Phase 2]
This Phase 2 clinical trial update reports results for a second-line treatment in patients with platinum-sensitive ovarian cancer. Sponsored…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 3]
A Phase 3 trial comparing paclitaxel and carboplatin with or without epirubicin in stage IIB-IV invasive ovarian epithelial, fallopian tube,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
A completed clinical trial evaluated dimesna in patients with solid tumors treated with cisplatin and paclitaxel. The study included head an…
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor [Phase 2]
A Phase 2 trial evaluating bevacizumab with allogeneic hematopoietic stem cell transplantation for advanced solid tumors, including breast a…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma [Phase 2]
Phase 2 study evaluating the combination of docetaxel and gemcitabine for platinum-resistant ovarian cancer and primary peritoneal carcinoma…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels [Phase 2]
Phase 2 trial evaluating the efficacy of Å6 in ovarian cancer patients who have completed first-line chemotherapy and show rising CA-125; th…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating 3-AP (triapine) with cisplatin in patients with recurrent or persistent platinum-resistant ovarian epithelial or pr…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
This Phase 2 trial of imatinib mesylate in patients with Stage III or Stage IV ovarian epithelial cancer or primary peritoneal cancer has co…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer [Phase 1]
Phase 1 study evaluating paclitaxel, cisplatin, and topotecan with or without filgrastim in newly diagnosed stage III or stage IV epithelial…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer [Phase 1]
Phase 1 trial evaluating a tumor vaccine in combination with interferon gamma for patients with refractory epithelial ovarian cancer has bee…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a four-drug chemotherapy regimen (gemcitabine, paclitaxel, ifosfamide, and cisplatin) for progressive or…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) [Phase 1, Phase 2]
This update reports results from a Phase 1/2 trial evaluating volociximab (M200) in combination with liposomal doxorubicin for ovarian cance…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer [Phase 2]
Phase 2 trial evaluating EF5 as an imaging agent to detect tumor hypoxia in patients with cervical, endometrial, or ovarian cancers undergoi…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating cisplatin and gemcitabine in patients with refractory or recurrent ovarian epithelial, fallopian tube, or primary p…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies [Phase 1]
Phase I study evaluating intravenous Triapine in combination with pelvic radiation therapy, with or without weekly cisplatin, for locally ad…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: A Study of Trabectedin in Patients With Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial update of trabectedin in advanced ovarian cancer (completed).
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients [Phase 2]
This clinical trial update reports results from a Phase 2 study evaluating a 2-hour infusion of ON 01910.Na in patients with ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2013-01-01Clinical Trial Update: Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating intravenous AVE0005 (aflibercept) in advanced ovarian cancer with recurrent symptomatic malignant asc…
-
CLINICAL_TRIALS trial_result · 2012-12-28Clinical Trial Update: PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer [Phase 1]
Phase I trial evaluating the SRC kinase inhibitor dasatinib in combination with paclitaxel and carboplatin for ovarian, peritoneal, and fall…
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer [Phase 2]
Phase 2 trial evaluating olaparib in combination with carboplatin and paclitaxel versus carboplatin and paclitaxel in advanced ovarian cance…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer [Phase 2]
The Phase 2 study evaluating the combination of Iressa (gefitinib) and Anastrozole (Arimidex) in ovarian, peritoneal, and tubal carcinomas h…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating sorafenib (Nexavar) versus placebo as maintenance therapy in advanced ovarian or primary peritoneal cancer; results…